SB0679 Summary

• Allows health care professionals to store and dispense opioid antagonists in hospitals, hospital affiliates, and ambulatory treatment centers without patient-specific labels if patient information is provided.

• Requires the Department of Human Services to develop policy and best practice guidelines for identification of at-risk individuals through SBIRT (Screening, Brief Intervention, and Referral to Treatment) and establishes contract or billing requirements for SBIRT services.

• Requires the Department of Healthcare and Family Services to develop and seek federal approval for a SBIRT benefit with bundled reimbursement rates for qualified providers.

• Mandates insurance coverage for all FDA-approved opioid antagonists including medication, administration devices, and pharmacy fees; requires health plans covering hospital expenses to reimburse hospitals for opioid antagonist costs upon discharge.

• Requires Medicaid coverage of pharmacy and hospital fees related to opioid antagonist dispensing, distribution, and administration for overdose treatment.